Eudaimonia Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Eudaimonia Partners’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,857	Closed	-$386K	–	260
2023 Q3	$386K	Buy	9,857 +12	+0.1%	+$478	0.09%	203
2023 Q2	$400K	Buy	9,845 +12	+0.1%	+$494	0.09%	212
2023 Q1	$412K	Buy	9,833 +611	+7%	+$25.7K	0.1%	209
2022 Q4	$402K	Buy	9,222 +10	+0.1%	+$425	0.1%	200
2022 Q3	$358K	Buy	9,212 +711	+8%	+$30.3K	0.09%	206
2022 Q2	$360K	Buy	8,501 +7	+0.1%	+$304	0.07%	268
2022 Q1	$387K	Buy	+8,494	New	+$376K	0.07%	278
2021 Q3	$400K	Hold	8,390	–	–	0.07%	260
2021 Q2	$407K	Buy	8,390 +50	+0.6%	+$2.39K	0.08%	256
2021 Q1	$386K	Buy	8,340 +100	+1%	+$4.74K	0.08%	238
2020 Q4	$392K	Buy	8,240 +265	+3%	+$12K	0.09%	218
2020 Q3	$342K	Buy	7,975 +2,800	+54%	+$120K	0.09%	215
2020 Q2	$211K	Buy	5,175 +300	+6%	+$12.1K	0.08%	228
2020 Q1	$176K	Buy	+4,875	New	+$194K	0.08%	235

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Eudaimonia Partners's BME Position: Q4 2023 in Review

Eudaimonia Partners sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 9,857 shares — an estimated $386K sold.

Eudaimonia Partners first reported a position in BME in Q1 2020 and held it in 14 quarters. The position peaked at $412K in Q1 2023. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

Eudaimonia Partners reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
Eudaimonia Partners sold 9,857 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $386K.
Eudaimonia Partners first reported a position in BlackRock Health Sciences Trust in Q1 2020 and held it in 14 quarters.
Eudaimonia Partners's BlackRock Health Sciences Trust position peaked at $412K in Q1 2023.
73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Eudaimonia Partners's 13F filing for Q4 2023, filed 8 Feb 2024.